Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

by David J Brooks
Published 2008-03-01

Extrastriatal monoamine neuron function in Parkinson’s disease: An 18F-dopa PET study

by Robert Y. Moore, Alan L. Whone, David J. Brooks
Published 2008-03-01

Imaging Parkinson’s disease below the neck

by Per Borghammer, Karoline Knudsen, Tatyana D. Fedorova, David J. Brooks
Published 2017-04-01

Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients

by Marios Politis, Heather Wilson, Kit Wu, David J. Brooks, Paola Piccini
Published 2017-01-01

Serotonergic mediated body mass index changes in Parkinson's disease

by Marios Politis, Clare Loane, Kit Wu, David J. Brooks, Paola Piccini
Published 2011-09-01

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

by Marios Politis, Kit Wu, Clare Loane, Lorenzo Kiferle, Sophie Molloy, David J. Brooks, Paola Piccini
Published 2010-10-01

The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer’s Disease

by Rola Ismail, Allan K. Hansen, Peter Parbo, Hans Brændgaard, Hanne Gottrup, David J. Brooks, Per Borghammer
Published 2018-01-01

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease

by Peter Parbo, Lasse Stensvig Madsen, Rola Ismail, Henrik Zetterberg, Kaj Blennow, Simon F. Eskildsen, Thomas Vorup-Jensen, David J. Brooks
Published 2020-01-01

Brain monoamine systems in multiple system atrophy: A positron emission tomography study

by Stephanie J. Lewis, Nicola Pavese, Maria Rivero-Bosch, Karla Eggert, Wolfgang Oertel, Christopher J. Mathias, David J. Brooks, Alex Gerhard
Published 2012-04-01

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers

by Nicola Pavese, Marios Politis, Yen F. Tai, Roger A. Barker, Sarah J. Tabrizi, Sarah L. Mason, David J. Brooks, Paola Piccini
Published 2010-02-01

Simplifying [18F]GE-179 PET: are both arterial blood sampling and 90-min acquisitions essential?

by Colm J. McGinnity, Daniela A. Riaño Barros, William Trigg, David J. Brooks, Rainer Hinz, John S. Duncan, Matthias J. Koepp, Alexander Hammers
Published 2018-06-01

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

by Alexander Gerhard, Nicola Pavese, Gary Hotton, Federico Turkheimer, Meltem Es, Alexander Hammers, Karla Eggert, Wolfgang Oertel, Richard B. Banati, David J. Brooks
Published 2006-02-01

Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease

by Rune B. Nielsen, Peter Parbo, Rola Ismail, Rikke Dalby, Anna Tietze, Hans Brændgaard, Hanne Gottrup, David J. Brooks, Leif Østergaard, Simon F. Eskildsen
Published 2020-01-01

A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.

by Kallol Ray Chaudhuri, Jose Manuel Rojo, Anthony H V Schapira, David J Brooks, Fabrizio Stocchi, Per Odin, Angelo Antonini, Richard G Brown, Pablo Martinez-Martin
Published 2013-01-01

Correction: A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need.

by Kallol Ray Chaudhuri, Jose Manuel Rojo, Anthony H V Schapira, David J Brooks, Fabrizio Stocchi, Per Odin, Angelo Antonini, Richard G Brown, Pablo Martinez-Martin
Published 2016-01-01

Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.

by Lucy J Garvey, Nicola Pavese, Anil Ramlackhansingh, Emma Thomson, Joanna M Allsop, Marios Politis, Ranjababu Kulasegaram, Janice Main, David J Brooks, Simon D Taylor-Robinson, Alan Winston
Published 2012-01-01

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats

by Majken B. Thomsen, Sara A. Ferreira, Anna C. Schacht, Jan Jacobsen, Mette Simonsen, Cristine Betzer, Poul H. Jensen, David J. Brooks, Anne M. Landau, Marina Romero-Ramos
Published 2021-02-01

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

by Paul Edison, Hilary A. Archer, Alexander Gerhard, Rainer Hinz, Nicola Pavese, Federico E. Turkheimer, Alexander Hammers, Yen Fong Tai, Nick Fox, Angus Kennedy, Martin Rossor, David J. Brooks
Published 2008-12-01

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study

by Rola Ismail, Peter Parbo, Lasse Stensvig Madsen, Allan K. Hansen, Kim V. Hansen, Jeppe L. Schaldemose, Pernille L. Kjeldsen, Morten G. Stokholm, Hanne Gottrup, Simon F. Eskildsen, David J. Brooks
Published 2020-05-01

Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder

by Morten Gersel Stokholm, Alex Iranzo, Karen Østergaard, Mónica Serradell, Marit Otto, Kristina Bacher Svendsen, Alicia Garrido, Dolores Vilas, Peter Parbo, Per Borghammer, Joan Santamaria, Arne Møller, Carles Gaig, David J. Brooks, Eduardo Tolosa, Nicola Pavese
Published 2018-07-01